Pharmacovigilance

Critique and Ways Forward

  • I. Ralph Edwards
  • Marie Lindquist

Table of contents

  1. Front Matter
    Pages i-xxxi
  2. Raquel Herrera Comoglio, Luis Alesso
    Pages 1-8
  3. Pia Caduff-Janosa
    Pages 9-19
  4. Alfonso Carvajal, Teresa Falomir, Carmelo Aguirre
    Pages 31-33
  5. Giovanni Furlan, Barry Burnstead
    Pages 55-66
  6. Ambrose O. Isah, Ivor Ralph Edwards
    Pages 99-114
  7. Ronald H. B. Meyboom, Hubert G. M. Leufkens, Eugène P. van Puijenbroek
    Pages 115-120
  8. Eugène P. van Puijenbroek, Linda Harmark
    Pages 131-144
  9. Souad Skalli, Scott A. Jordan
    Pages 145-159
  10. Shirley-Ann van der Spuy
    Pages 161-172
  11. Giampaolo Velo
    Pages 195-205

About this book

Introduction

Written by experienced authors, this book offers expert personal views on what the current problems in pharmacovigilance are and how they should be solved. This book stems from thoughts and ideas discussed in a series of meetings of the International Society of Pharmacovigilance (ISoP), where concerns were raised that the current pharmacovigilance system is not delivering optimally to improve therapeutics in clinical practice.

Pharmacovigilance of the future must be an active and integral part of health care delivery, and focus more on science and practices that support health professionals and patients in day-to-day care situations. To achieve this, a dynamic and sustainable development of vigilance must take precedence over the current excessive preoccupations with data processing and regulations; all aspects of medicines use and their effects need to be considered; and all stakeholders must be involved and engaged in an open and constructive debate.

The work is essential reading for anyone who has an interest in safer use of medicines. It is intended to be equally challenging and rewarding, and sets out to stimulate a continuous debate on how pharmacovigilance can better meet the needs of health professionals and patients to achieve the aim of wise therapeutic decision making.

Keywords

Best Practices Communication Critical Thinking Culture Decision Making Drug Safety Monitoring Risks and Benefits Science and Bureaucracy

Editors and affiliations

  • I. Ralph Edwards
    • 1
  • Marie Lindquist
    • 2
  1. 1.Uppsala Monitoring CentreUppsalaSweden
  2. 2.Uppsala Monitoring CentreUppsalaSweden

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-40400-4
  • Copyright Information Springer International Publishing Switzerland 2017
  • Publisher Name Adis, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-40399-1
  • Online ISBN 978-3-319-40400-4
  • About this book